PI vs. ABCL
PI (Impinj, Inc.) and ABCL (AbCellera Biologics Inc.) are both stocks. PI operates in Communication Equipment (Technology), while ABCL operates in Biotechnology (Healthcare). Over the past 5 years, PI returned 20.89%/yr vs -23.36%/yr for ABCL. At a 0.33 correlation, their price movements are largely independent.
Performance
PI vs. ABCL - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PI achieves a -24.38% return, which is significantly lower than ABCL's 67.84% return.
PI
- 1D
- 2.24%
- 1M
- -12.13%
- YTD
- -24.38%
- 6M
- -26.18%
- 1Y
- 27.05%
- 3Y*
- 14.79%
- 5Y*
- 20.89%
- 10Y*
- —
ABCL
- 1D
- 3.80%
- 1M
- 10.38%
- YTD
- 67.84%
- 6M
- 54.30%
- 1Y
- 68.33%
- 3Y*
- -7.74%
- 5Y*
- -23.36%
- 10Y*
- —
PI vs. ABCL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
PI Impinj, Inc. | -24.38% | 19.79% | 61.35% | -17.54% | 23.09% | 111.85% | 0.62% |
ABCL AbCellera Biologics Inc. | 67.84% | 16.72% | -48.69% | -43.63% | -29.16% | -64.46% | -34.03% |
Correlation
The correlation between PI and ABCL is 0.27, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.27 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.27 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.34 |
Correlation (All Time) Calculated using the full available price history since Dec 11, 2020 | 0.33 |
Fundamentals
PI:
$3.99B
ABCL:
$1.74B
PI:
-$0.93
ABCL:
-$0.48
PI:
10.88
ABCL:
21.73
PI:
19.55
ABCL:
1.85
PI:
$361.05M
ABCL:
$79.21M
PI:
$188.92M
ABCL:
$70.89M
PI:
-$4.74M
ABCL:
-$166.07M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PI vs. ABCL — Risk / Return Rank
PI
ABCL
PI vs. ABCL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Impinj, Inc. (PI) and AbCellera Biologics Inc. (ABCL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| PI | ABCL | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.52 | ||
| Sortino ratioReturn per unit of downside risk | -0.64 | ||
| Omega ratioGain probability vs. loss probability | 1.13 | 1.19 | -0.06 |
| Calmar ratioReturn relative to maximum drawdown | 0.44 | 1.25 | -0.81 |
| Martin ratioReturn relative to average drawdown | 0.78 | 2.27 | -1.49 |
Loading charts...
Drawdowns
PI vs. ABCL - Drawdown Comparison
The maximum PI drawdown since its inception was -81.35%, smaller than the maximum ABCL drawdown of -96.84%. Use the drawdown chart below to compare losses from any high point for PI and ABCL.
Loading charts...
Drawdown Indicators
| PI | ABCL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -81.35% | -96.84% | +15.49% |
Max Drawdown (1Y)Largest decline over 1 year | -62.24% | -54.94% | -7.30% |
Max Drawdown (3Y)Largest decline over 3 years | -73.79% | -75.72% | +1.93% |
Max Drawdown (5Y)Largest decline over 5 years | -73.79% | -91.23% | +17.44% |
Current DrawdownCurrent decline from peak | -45.60% | -90.59% | +44.99% |
Average DrawdownAverage peak-to-trough decline | -36.72% | -84.16% | +47.44% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 34.84% | 30.22% | +4.62% |
Volatility
PI vs. ABCL - Volatility Comparison
The current volatility for Impinj, Inc. (PI) is 22.22%, while AbCellera Biologics Inc. (ABCL) has a volatility of 27.02%. This indicates that PI experiences smaller price fluctuations and is considered to be less risky than ABCL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PI | ABCL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 22.22% | 27.02% | -4.80% |
Volatility (6M)Calculated over the trailing 6-month period | 57.66% | 55.30% | +2.36% |
Volatility (1Y)Calculated over the trailing 1-year period | 75.87% | 77.92% | -2.05% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 69.79% | 66.88% | +2.91% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 72.88% | 70.26% | +2.62% |
Dividends
PI vs. ABCL - Dividend Comparison
Neither PI nor ABCL has paid dividends to shareholders.
Financials
PI vs. ABCL - Financials Comparison
This section allows you to compare key financial metrics between Impinj, Inc. and AbCellera Biologics Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
PI and ABCL have a correlation of 0.27, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ABCL has higher volatility (27.02%) compared to PI (22.22%). In terms of maximum drawdown, PI dropped -81.35% vs ABCL's -96.84%.
ABCL currently has the higher Sharpe Ratio (0.88 vs 0.36), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PI and ABCL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer